Brinton Todd J.
TODD J. BRINTON, MD
Clinical Professor of Medicine, Stanford University
Adjunct Professor, Bioengineering
Fellowship Director, Stanford Biodesign
Dr. Brinton is a Clinical Professor of Medicine (Cardiology) and Adjunct Professor of Bioengineering at Stanford University. He is also an attending interventional cardiologist at both Stanford University Medical Center and the Palo Alto VA Medical Center. He has served as the fellowship director for the Stanford Byers Center for Biodesign since 2005 and also co-directs both the executive education program in innovation management and the graduate course series in biodesign innovation at Stanford.
Dr. Brinton lectures on strategies for innovation and serves as a mentor to innovation fellows, graduate students, and healthcare executives. His academic research focuses on the process of innovation for development of novel medical technologies. He specifically focuses on the integration of research and development for new technologies with the clinical strategy and pre-clinical evaluation. His primary clinical interest is the treatment of complex coronary disease and he has served as a clinical investigator for several studies of interventional-based therapies for ischemia heart disease and heart failure.
Dr. Brinton completed his internal medicine, cardiology, and interventional cardiology training at Stanford University. He holds an MD from the Chicago Medical School and a BS in Bioengineering from the University of California, San Diego. He is co-founder and board director for Shockwave Medical and BioParadox, Inc., which are both venture-backed medical device companies in the cardiovascular space. He served on the board of directors of Infogard Laboratories prior to acquisition. He also serves on the advisory board of a number of early-stage medical device companies where he focuses on both technical and clinical development strategy. Prior to medical school, he was the Clinical Research Director for Pulse Metric, Inc., a venture-backed medical device start-up company.